Exploring Fatty Acid Mimetics as NR4A Ligands.

Area of Science:

• Molecular Biology
• Pharmacology
• Drug Discovery

Background:

• The NR4A nuclear receptor family (Nur77, Nurr1, NOR-1) are implicated in neurodegeneration and cancer.
• Pharmacological modulation of NR4A receptors is crucial for target validation but lacks sufficient chemical tools.
• Emerging evidence indicates NR4A receptors interact with fatty acid metabolites and fatty acid mimetic (FAM) drugs.

Purpose of the Study:

• To explore the chemical space of FAM NR4A ligands.
• To identify novel chemical scaffolds for NR4A receptor modulation.
• To develop potential therapeutic agents targeting NR4A pathways.

Main Methods:

• Fragment screening of a diverse chemical library (92 fragments).
• In silico analysis and systematic structure-activity relationship (SAR) evaluation.
• Optimization of identified FAM NR4A ligand scaffolds.

Main Results:

• Identification of 11 new FAM NR4A agonist and inverse agonist scaffolds.
• Discovery of potent NR4A agonists with submicromolar potency and binding affinity after structural optimization.
• Demonstration of FAM compounds as viable tools for NR4A receptor modulation.

Conclusions:

• Fatty acid mimetics (FAMs) represent a promising chemical class for developing NR4A receptor modulators.
• Optimized FAM ligands hold significant potential as therapeutic drugs for NR4A-related pathologies.
• This study expands the toolkit for NR4A-targeted drug discovery.